The objective of this study is to evaluate if use of a patient decision aid (PDA), when choosing between a repeat cesarean or a trial of labor after a cesarean (TOLAC), reduces medical liability exposure. The authors conclude that use of a PDA conferred liability protection when potential jurors were presented with a hypothetical malpractice claim against an obstetrician following a TOLAC.
Get full access to this article
View all access options for this article.
References
1.
K.D.Gregory, M.Fridman, and L.Korst, “Trends and Patterns of Vaginal Birth After Cesarean Availability in the United States,”Seminars in Perinatology34, no. 4 (2010): 237-243.
2.
J.K.Gupta, G.C.S.Smith, and R.R.Chodankar, “Birth After Previous Cesarean Birth,” Green-top Guideline, London: Royal College of Obstetricians & Gynaecologists, 2015. Report No. 45; American College of Obstetricians and Gynecologists, ACOG Practice Bulletin no. 115, “Vaginal Birth After Previous Cesarean Delivery,” Obstetrics & Gynecology 116 no. 2 Pt 1 (2010): 450-463.
3.
K.J.Cox, “Providers’ Perspectives on the Vaginal Birth after Cesarean Guidelines in Florida, United States: A Qualitative Study,”BMC Pregnancy Childbirth11, no. 72 (2011): 1-12; M.K. Barger, J.T. Dunn, S. Bearman, M. DeLain, and E. Gates “A Survey of Access to Trial of Labor in California Hospitals in 2012,” BMC Pregnancy Childbirth 13, no. 83 (2013): 2-10.
4.
L.M.Korst, K.D.Gregory, M.Fridman, and J.P.Phelan“Nonclinical Factors Affecting Women’s Access to Trial of Labor after Cesarean Delivery,”Clinics in Perinatology38, no. 2 (2011):193-216; L.M. Leeman, M. Beagle, E. Espey, T. Ogburn, and B. Skipper “Diminishing Availability of Trial of Labor After Cesarean Delivery in New Mexico Hospitals,” Obstetrics & Gynecology 122 no. 2 Pt 1 (2013): 242-247.
5.
Y.T.Yang, M.M.Mello, S.V.Subramanian, and D.M.Studdert, “Relationship Between Malpractice Litigation Pressure and Rates of Cesarean Section and Vaginal Birth after Cesarean Section,”Medical Care47, no. 2 (2009): 234-242.
6.
A.G.Mulley, C.Trimble, and G.Elwyn“Stop the Silent Mis-diagnosis: Patients’ Preferences Matter,”BMJ345 (2012): e6572.
7.
D.Stacey, F.Legare, K.Lewis, M.J.Barry, C.L.Bennett, K.B.Eden, et al., “Decision Aids for People Facing Health Treatment or Screening Decisions,”Cochrane Database of Systematic Reviews4 (2017): CD001431.
8.
M.J.Barry, P.H.Wescott, E.J.Reifler, Y.Chang, and B.W.Moulton“Reactions of Potential Jurors to a Hypothetical Malpractice Suit Alleging Failure to Perform a Prostate-Specific Antigen Test,”Journal of Law Medicine & Ethics36, no. 2 (2008): 396-402.
9.
T.M.Pope and D.Lessler, “Revolutionizing Informed Consent: Empowering Patients with Certified Decision Aids,”Patient (March31, 2017).
10.
T.Bourne, L.Wynants, M.Peters, C.Van Audenhove, D.Timmerman, B.Van Calster, et al., “The Impact of Complaints Procedures on the Welfare, Health and Clinical Practise of 7926 Doctors in the UK: A Cross-Sectional Survey,”BMJ Open5, no. 1 (2015): e006687,2014-006687; O. Ortashi, J. Virdee, R. Hassan, T. Mutrynowski, and F. Abu-Zidan, “The Practice of Defensive Medicine among Hospital Doctors in the United Kingdom,” BMC Medical Ethics 14 (2013): 1-6; D.M. Studdert, M.M. Mello, W.M. Sage, C.M. DesRoches, J. Peugh, K. Zapert, et al., “Defensive Medicine among High-Risk Specialist Physicians in a Volatile Malpractice Environment,” JAMA 293, no. 21 (2005): 2609-2617.
11.
See Cox, supra note 3; see Yang, supra note 5; Y.W.Cheng, J.M.Snowden, S.J.Handler, I.B.Tager, A.E.Hubbard, and A.B.Caughey, “Litigation in Obstetrics: Does Defensive Medicine Contribute to Increases in Cesarean Delivery?”Journal of Maternal Fetal Neonatal Medicine27, no. 16 (2014): 1668-1675; F.A. Chervenak and L.B. McCullough, “Ethical Issues in Cesarean Delivery,” Best Practice & Research: Clinical Obstetrics & Gynaecology 43 (2017): 68-75; G. Gochnour S. Ratcliffe, and M.B. Stone, “The UTAH VBAC study,” Maternal and Child Health Journal 9, no. 2 (2005): 181-188; C.E. Wells, “Vaginal Birth after Cesarean Delivery: Views from the Private Practitioner,” Seminars in Perinatology 34, no. 5 (2010): 345-350.
12.
See Chervenak, supra note 11; M.F.Malik, A.O.Awonuga, and C.B.Iglesia, “Informed Consent for Vaginal Delivery: Is it Time to Revisit the Shared Decision-Making Process?”Journal of Reproductive Medicine61, no. 3-4 (2016): 153-158.
13.
See Stacey, supra note 7.
14.
A.M.Friedman and S.K.Srinivas, “Is Documentation of TOLAC Counseling a Good Measure of Quality of Care?”Journal of Maternal-Fetal and Neonatal Medicine29, no. 11 (2016): 1710-1714.
15.
R.M.Scaffidi, B.Posmontier, J.R.Bloch, and R.Wittmann-Price, “The Relationship Between Personal Knowledge and Decision Self-Efficacy in Choosing Trial of Labor after Cesarean,”Journal of Midwifery & Women’s Health59, no. 3 (2014): 246-253.
